CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry

NEXT STORY
RedHill Biopharma’s Opaganib COVID-19 Study Passes Second Independent Committee Review
PREV STORY
Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atara Biotherapeutics to Present at Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 24, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Positive Top-Line Results from Confirmatory Phase 3 Study with TALICIA® for H. pylori Infection

The ERADICATE Hp2 confirmatory Phase 3 study successfully met its primary endpoint of H. ...

author_avatar
NASDAQ Market News

Sensus Healthcare and David Goldberg, M.D., J.D. to Host a Virtual Program on Dermatology Medical and Legal Issues in the Era of COVID-19

author_avatar
NASDAQ Market News